临床试验：PX-171-001-蛋白酶体抑制剂剂量递增的 I 期研究-猫眼课题宝

临床试验：PX-171-001-蛋白酶体抑制剂剂量递增的 I 期研究

批准号：

7716842

负责人：

PETER VOORHEES

金额：

$0.42万

依托单位：

UNIV OF NORTH CAROLINA CHAPEL HILL

依托单位国家：

美国

项目类别：

财政年份：

2008

资助国家：

美国

项目状态：

已结题

起止时间：

2008-04-02 至 2008-05-31

来源：

https://reporter.nih.gov/project-details/7716842

关键词：

Clinical Trials Computer Retrieval of Information on Scientific Projects Database Dose Funding Grant Institution Investigational Drugs Learning Phase I Clinical Trials Purpose Research Research Personnel Resources Safety Source United States National Institutes of Health multicatalytic endopeptidase complex research study

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to learn about the safety of an investigational drug called PR-171 at different dose levels.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文